| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |